Work

Dupilumab Improves Post-bronchodilator Lung Function in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Type 2 Inflammation: Data From the Phase 3 Boreas Trial

Year: 2024

Type: conference-abstract

DOI: 10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a1200

Authors: N.A. Hanania, S.P. Bhatt, K.F. Rabe, C.F. Vogelmeier, M. Bafadhel, S.A. Christenson, A. Papi, D. Singh, E. Laws, C. Nivens, A. Bansal, X. Lu, D. Bauer, J. Maloney, L.B. Robinson, R.M. Abdulai

Institutions: Baylor College of Medicine, University of Alabama at Birmingham, German Center for Lung Research, LungenClinic Grosshansdorf, Philipps University of Marburg, King's College London, University of California, San Francisco, University of Ferrara, Arcispedale Sant'Anna, University of Manchester, Manchester University NHS Foundation Trust, Sanofi (United States), Regeneron (United States)

Language: English

Topic: Chronic Obstructive Pulmonary Disease (COPD) Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4396505568

Cites:

Cited by: 1

Related to: 10